Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer, will represent the company at the Citizens Life Sciences Conference …
Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced robust demand-led growth for its molluscum contagiosum treatment, YCANTH®, during the first quarter of 2025. The company reported a …
Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Gavin Corcoran to its Board of Directors.
Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology-focused therapeutics company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. Jayson Rieger, PhD, MBA, President and …
Verrica Pharmaceuticals to Present at Needham Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Noah L. Rosenberg as Chief Medical Officer, a strategic move aimed at strengthening the company’s efforts …
Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and CEO, Jayson Rieger, PhD, MBA, will participate in a fireside chat at the TD Cowen 45th …
Verrica Pharmaceuticals CEO to Speak at TD Cowen 45th Annual Health Care Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled encouraging clinical data for its investigational therapy, VP-315, at the 2025 Winter Clinical Dermatology Conference in Miami, Florida. The Phase 2 …
Verrica Showcases Promising VP-315 Data at Dermatology Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has provided an update on the commercial strategy for its flagship product YCANTH, a treatment for molluscum contagiosum. The company reported strong …
Verrica Pharmaceuticals Reports Progress on Molluscum Treatment and Pipeline Development Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced a significant stock option grant to David Zawitz, the company’s newly appointed Chief Operating Officer. The Compensation Committee approved a …
Verrica Pharmaceuticals Grants Stock Option to New COO David Zawitz Read More